SIGA Technologies Receives Approval from the European Medicines Agency for Tecovirimat

NEXT STORY
Cara Therapeutics Announces Difelikefalin (KORSUVA™) Injection Achieves Positive Topline Results in Phase 3 Clinical Study in Japan for the Treatment of Pruritus in Hemodialysis Patients
PREV STORY
TScan Outlines 2022 Priorities as Programs Enter Clinic
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Palisade Bio Launches Clinical Steering Committee to Provide Clinical Oversight and Guide Preparation for Late-Stage Clinical Trials of LB1148 in Accelerating Postoperative Return of Bowel Function and Reduction of Post-Surgical Adhesions

author_avatar
NASDAQ Market News

Nya data för simeprevir kommer att presenteras vid EASL:s International Liver Congress 2016

Stockholm — Medivir AB (Nasdaq Stockholm: MVIR) meddelar idag att nya kliniska data för ...

author_avatar
NASDAQ Market News

Novartis landmark study of Tafinlar® + Mekinist® demonstrates durable survival benefit at five years in patients with BRAF mutation-positive metastatic melanoma

Study is longest follow-up to date of a BRAF and MEK inhibitor combination therapy ...

author_avatar
NASDAQ Market News